Research Plan Responsibilities Sample Clauses

Research Plan Responsibilities. Each Party shall be responsible for conducting the activities assigned to it in the Research Plan and shall conduct such activities in accordance with the Research Plan and, in the case of Adverum, the Research Budget.
Sample 1Sample 2
AutoNDA by SimpleDocs
Research Plan Responsibilities. (a) Unless otherwise agreed by the Parties, the Parties acknowledge and agree that the responsibilities of the Parties in a Research Plan will generally be allocated as follows:
Sample 1
Research Plan Responsibilities. Unless otherwise agreed in writing by the Parties or expressly provided in the Research Plan, the allocation of responsibilities and obligations under the Research Plan shall be as follows: (a) Incyte shall solely have the obligation for (i) providing all samples from, or derived from, human subjects or cell lines that are necessary to perform the Research Program (collectively, “Samples”), including patient samples and control samples, in accordance with Section 2.12 and the Research Plan; (ii) performing the Definitive Validation Studies in accordance with Section 2.8.7 and the Research Plan; and (iii) performing any other research activities at Incyte’s election during or following the Research Term in relation to any Program Target with respect to which Incyte retains an unexercised Option, in accordance with the Research Plan; and (b) Syros, subject to Incyte’s rights and obligations under clause (a) and Section 2.8.5(a), under the oversight of the JRC, shall solely have the obligation for (i) analyzing the Pilot Samples in accordance with Section 2.8.1 and the Research Plan; (ii) analyzing the Supplemental Samples in accordance with Section 2.8.3 and the Research Plan; and (iii) performing the Initial Validation Studies in accordance with Section 2.8.5 and the Research Plan; in each case ((a) and (b)), subject to and in accordance with the terms of this Agreement. Notwithstanding anything to the contrary in this Agreement or the Research Plan, Syros shall not use any Syros Therapeutic in performing its obligations under this Agreement, including in performing its activities under the Research Plan. Without limiting the foregoing, Incyte shall have the right to use Program IP and Syros Existing Background Target IP to conduct validation activities and preclinical research on Program Targets pursuant to the license granted in Section 3.3.1(a).
Sample 1

Related to Research Plan Responsibilities

  • Development Responsibilities From and after the Effective Date, BMS shall assume sole responsibility for the Development of Compounds and Products in the Field in the Territory during the Term at its own cost and expense (including responsibility for all funding, resourcing and decision-making, subject to Sections 3.3 and 3.4), except with respect to the performance by Ambrx of the Research Program activities assigned to Ambrx pursuant to the Research Plan and as otherwise may be agreed upon by the Parties in writing. BMS, by itself or through its Affiliates and Sublicensees, shall use Diligent Efforts to Develop a Compound or Product in the Field in accordance with the Development Plan for the purpose of obtaining a Regulatory Approval in each Major Market. For clarity, it is understood and acknowledged that Diligent Efforts in the Development of Compounds and Products may include sequential implementation of Clinical Trials and/or intervals between Clinical Trials for data interpretation and clinical program planning and approval.

  • Specific Responsibilities In addition to its overall responsibility for monitoring and providing a forum to discuss and coordinate the Parties’ activities under this Agreement, the JSC shall in particular:

  • Client Responsibilities During the Term and subject to the provisions of this Schedule, Client shall at its expense (unless otherwise provided for herein) fulfill, or cause to be fulfilled by the Funds or otherwise, the Client obligations, if any, set forth in each Service Exhibit to this Schedule. Client hereby represents, warrants and covenants that the execution and delivery of this Schedule by Client and the performance of Client’s obligations under this Schedule have been duly authorized by all necessary action on the part of Client. Client must comply with the provisions of this Schedule. Client agrees that DST may seek relief from Client for any infringement of this Schedule such as, but not limited to, a material violation, breach, act of negligence or gross negligence, willful misconduct, misfeasance or malfeasance committed by Client or its officers, agents and assigns, in connection with Client’s obligations and responsibilities under this Schedule.

  • Joint Responsibilities In performing the Development Efforts, each party shall

  • ALPS’ Responsibilities In connection with its performance of TA Web, ALPS shall:

  • Regulatory Responsibilities Following the approval by the FDA of an ANDA, Xxxx shall be solely responsible, with Corium’s reasonable assistance, for maintaining the ANDA for the Product including any necessary periodic reporting requirements. Furthermore, Xxxx shall be responsible for all adverse event reporting as required by the Act. Xxxx agrees to perform these activities in conformance with cGMP, the ANDA specifications and the Act. Xxxx shall provide Corium with copies of all material correspondence from or to regulatory authorities in the Territory relating to the maintenance of the ANDA.

  • Scope of Delegated Responsibilities (a) SELECTION OF ELIGIBLE FOREIGN CUSTODIANS. Subject to the provisions of this Section 3.2, the Foreign Custody Manager may place and maintain the Foreign Assets in the care of the Eligible Foreign Custodian selected by the Foreign Custody Manager in each country listed on Schedule A, as amended from time to time. In performing its delegated responsibilities as Foreign Custody Manager to place or maintain Foreign Assets with an Eligible Foreign Custodian, the Foreign Custody Manager shall determine that the Foreign Assets will be subject to reasonable care, based on the standards applicable to custodians in the country in which the Foreign Assets will be held by that Eligible Foreign Custodian, after considering all factors relevant to the safekeeping of such assets, including, without limitation the factors specified in Rule 17f-5(c)(1).

  • Company Responsibilities The Company will undertake responsibilities as set forth below:

  • Position Duties Responsibilities 3.01 It is contemplated that at all times during the Period of Employment the Executive shall continue to serve as a principal officer of the Company with the office and title of Vice President, General Counsel of the Company and continue to have duties and responsibilities commensurate with those duties and responsibilities imposed on the Executive immediately prior to the Effective Date.

  • Role and Responsibilities During the Employment Period, the Executive shall serve as Chief Commercial Officer of the Company, and shall perform such employment duties as are usual and customary for such position. The Executive shall report directly to the Chief Executive Officer of the Company. At the Company’s request, the Executive shall serve the Company and/or its subsidiaries and affiliates in other capacities in addition to the foregoing, consistent with the Executive’s position as Chief Commercial Officer of the Company. In the event that the Executive serves in any one or more such additional capacities, the Executive’s compensation shall not be increased beyond that specified in Section 2(b) hereof. In addition, in the event the Executive’s service in one or more of such additional capacities is terminated, the Executive’s compensation, as specified in Section 2(b) hereof, shall not be diminished or reduced in any manner as a result of such termination, provided that the Executive otherwise remains employed under and performs the services contemplated by this Agreement.

Time is Money Join Law Insider Premium to draft better contracts faster.